PATENT CLAIM ANALYSIS

Application Number: 15752845
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["435", "325000"]

Abstract:
The present invention relates to compositions and methods for disrupting cancer stromal cell networks using synthetic nanoparticles coated with plasma membranes.

Claim (Index 22):
A method of treating cancer comprising:\n isolating a cancer cell from a subject; administering to the subject a composition comprising a nanoparticle, wherein the nanoparticle surface is encapsulated with one or more plasma membrane-associated components, and wherein the plasma membrane is derived from the cancer cell; and activating an immune response against the cancer cell in the subject, thereby treating the cancer.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 88.0
- Lexical Diversity: 1.0
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15545937', '14449590', '15699796', '14233215', '14726770']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6043844315512535
- 35 USC 102 Novelty (BERT): 0.5034012913849347
- Combined Prediction Score: 0.5942861175346217
- Mean Citation Score: 245.999092
- Max Citation Score: 259.45413
- Similarity Product: 173.5310865501702

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test